FNDC5 |
PTS |
||
---|---|---|---|
Gene Name | fibronectin type III domain containing 5 | 6-pyruvoyltetrahydropterin synthase | |
Image | No pdb structure | ||
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process | |||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 1 interactors: PTS | 12 interactors: ATM ATR COIL FNDC5 FXR2 LNX1 PBRM1 PRKDC PRKG2 SDCBP THAP10 WDYHV1 | |
Entrez ID | 252995 | 5805 | |
HPRD ID | 17009 | 11840 | |
Ensembl ID | ENSG00000160097 | ENSG00000150787 | |
Uniprot IDs | Q8NAU1 | Q03393 | |
PDB IDs | 3I2B | ||
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | adipokine
adipose
adiposity
arose
artefact
attempt
circulating
circulation
clarify
controversy
counteract
disturbances
doubts
fibronectin
homoeostasis
humans
inconsistencies
irisin
obesity
participation
pathologies
postulated
proliferated
questionable
raise
really
reflecting
soon
unpredicted
|
achieve
aida
apl
atra
became
chemotherapy
consolidation
converting
courses
cytogenetic
fab
gimema
hematologic
interpretation
lap0493
m3
majority
molecularly
morphologic
mths
myelogenous
persistence
promyelocytic
q12
q22
remission
successive
transcript
validity
|
|
Tagcloud (Difference) ? | adipokine
adipose
adiposity
arose
artefact
attempt
circulating
circulation
clarify
controversy
counteract
disturbances
doubts
fibronectin
homoeostasis
humans
inconsistencies
irisin
obesity
participation
pathologies
postulated
proliferated
questionable
raise
really
reflecting
soon
unpredicted
|
achieve
aida
apl
atra
became
chemotherapy
consolidation
converting
courses
cytogenetic
fab
gimema
hematologic
interpretation
lap0493
m3
majority
molecularly
morphologic
mths
myelogenous
persistence
promyelocytic
q12
q22
remission
successive
transcript
validity
|
|
Tagcloud (Intersection) ? |